최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓齒科醫師協會誌 = The journal of the Korean dental association, v.53 no.1, 2015년, pp.28 - 35
황순정 (서울대학교 치의학대학원) , 박민우 (서울대학교 치의학대학원) , 박재봉 (서울대학교 치의학대학원) , 박현수 (서울대학교 치의학대학원) , 백승준 (서울대학교 치의학대학원) , 설희경 (서울대학교 치의학대학원) , 이경진 (서울대학교 치의학대학원) , 홍동환 (서울대학교 치의학대학원)
To overcome shortcoming of autogeneous, allogenic, xenogenic and alloplastic bone grafts, various growth factors related to bone regeneration have been identified and developed. Among them, rhBMP-2 is regarded as the most potent osteoinductive growth factor and it can trigger the differentiation of ...
Chiapasco M, Di Martino G, Anello T, Zaniboni M, Romeo E: Fresh Frozen versus Autogenous Iliac Bone for the Rehabilitation of the Extremely Atrophic Maxilla with Onlay Grafts and Endosseous Implants: Preliminary Results of a Prospective Comparative Study. Clin Implant Dent Relat Res, 2013
Martuscelli R, Toti P, Sbordone L, Guidetti F, Ramaglia L, Sbordone C: Five-year outcome of bone remodelling around implants in the maxillary sinus: assessment of differences between implants placed in autogenous inlay bone blocks and in ungrafted maxilla. Int J Oral Maxillofac Surg, 2014
von Arx T, Cochran DL, Hermann JS, Schenk RK, Buser D: Lateral ridge augmentation using different bone fillers and barrier membrane application. A histologic and histomorphometric pilot study in the canine mandible. Clin Oral Implants Res 12: 260-269, 2001
de Lange GL, Overman JR, Farre-Guasch E, Korstjens CM, Hartman B, Langenbach GE, et al: A histomorphometric and micro-computed tomography study of bone regeneration in the maxillary sinus comparing biphasic calcium phosphate and deproteinized cancellous bovine bone in a human split-mouth model. Oral Surg Oral Med Oral Pathol Oral Radiol 117: 8-22, 2014
Bignon A, Chouteau J, Chevalier J, Fantozzi G, Carret JP, Chavassieux P, Boivin G, Melin M, Hartmann D. Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response. Journal of Materials Science: Materials in Medicine 14:1089-1097, 2003
Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, et al: Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 67: 1947-1960, 2009
Gutwald R, Haberstroh J, Stricker A, Ruther E, Otto F, Xavier SP, et al: Influence of rhBMP-2 on bone formation and osseointegration in different implant systems after sinus-floor elevation. An in vivo study on sheep. J Craniomaxillofac Surg 38: 571-579, 2010
Carragee EJ, Hurwitz EL, Weiner BK: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11: 471-491, 2011
Urist MR: Bone: formation by autoinduction. Science 150: 893-899, 1965
Carreira AC, Lojudice FH, Halcsik E, Navarro RD, Sogayar MC, Granjeiro JM: Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res 93: 335-345, 2014
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al: Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534, 1988
Bessho K, Konishi Y, Kaihara S, Fujimura K, Okubo Y, Iizuka T: Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2. Br J Oral Maxillofac Surg 38: 645-649, 2000
Yano K, Hoshino M, Ohta Y, Manaka T, Naka Y, Imai Y, et al: Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing. J Bone Miner Metab 27: 355-363, 2009
Kim IS, Lee EN, Cho TH, Song YM, Hwang SJ, Oh JH, et al: Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. Tissue Eng Part A 17: 337-348, 2011
Kim RY, Oh JH, Lee BS, Seo YK, Hwang SJ, Kim IS. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterilas 35: 1869-1881, 2014
Jung RE, Glauser R, Scharer P, Hammerle CH, Sailer HF, Weber FE: Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 14: 556-568, 2003
Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, et al: De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63: 1693-1707, 2005
Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, et al: Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 67: 1947-1960, 2009
Lee YM, Shin SY, Kim JY, Kye SB, Ku Y, Rhyu IC: Bone reaction to bovine hydroxyapatite for maxillary sinus floor augmentation: histologic results in humans. Int J Periodontics Restorative Dent 26: 471-481, 2006
de Freitas RM, Susin C, Spin-Neto R, Marcantonio C, Wikesjo UM, Pereira LA, Marcantonio E Jr. Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial. J Clin Periodontol. 40:968-75, 2013
Carter TG, Brar PS, Tolas A, Beirne OR. Off-label use of recombinant human bone morphogenetic protein-2(rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg. 66:1417-25, 2008
Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2(rhBMP-2). J Oral Maxillofac Surg. 66:616-24, 2008
Herford AS, Boyne PJ, Rawson R, Williams RP: Bone morphogenetic protein-induced repair of the premaxillary cleft. J Oral Maxillofac Surg 65: 2136-2141, 2007
Pradel W, Lauer G: Tissue-engineered bone grafts for osteoplasty in patients with cleft alveolus. Ann Anat 194: 545-548, 2012
Neovius E, Lemberger M, Docherty Skogh AC, Hilborn J, Engstrand T: Alveolar bone healing accompanied by severe swelling in cleft children treated with bone morphogenetic protein-2 delivered by hydrogel. J Plast Reconstr Aesthet Surg 66: 37-42, 2013
Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol. 76:605-13, 2005
Chrastil J, Low JB, Whang PG, Patel AA. Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine. Spine(Phila Pa 1976) 38:E1020-E1027, 2013.
Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjo UM(2008). Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations. Clin Oral Implants Res 19:1027-1033, 2008
Devine JG, Dettori JR, France JC, Brodt E, McGuire RA. The use of rhBMP in spine surgery: is there a cancer risk? Evid Based Spine Care J 3:35-41, 2012
※ AI-Helper는 부적절한 답변을 할 수 있습니다.